Provided herein are solid forms comprising (a) 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and (b) a coformer. Pharmaceutical compositions comprising the solid forms (e.g., cocrystals) and methods for treating, preventing and managing various disorders are also disclosed.

The present invention relates generally to methods for producing renewable detergent compounds. More specifically, the invention relates to methods for producing detergent intermediates, including bio-linear alkylbenzene (LAB), bio-alcohols, and long chain bio-paraffins, from natural oils.

The present invention relates generally to methods for producing renewable detergent compounds. More specifically, the invention relates to methods for producing detergent intermediates, including bio-linear alkylbenzene (LAB), bio-alcohols, and long chain bio-paraffins, from natural oils.

Provided herein are solid forms comprising (a) 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and (b) a coformer. Pharmaceutical compositions comprising the solid forms (e.g., cocrystals) and methods for treating, preventing and managing various disorders are also disclosed.

The invention is directed to pharmaceutically acceptable salts of suvorexant, which is an antagonist of orexin receptors. The pharmaceutically acceptable salts of suvorexant are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is further directed to pharmaceutical compositions comprising pharmaceutically acceptable salts of suvorexant.

The invention is directed to pharmaceutically acceptable salts of suvorexant, which is an antagonist of orexin receptors. The pharmaceutically acceptable salts of suvorexant are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is further directed to pharmaceutical compositions comprising pharmaceutically acceptable salts of suvorexant.

This invention refer to a series of substances according to formula I: ##STR00001## The substances according to formula I above, known as sulphate chelating agent have the ability to enlarge/loosen simple cell membrane nor common organic membrane and its synthesis process. Furthermore, these invented substances have the potential as the biocides raw material, with very low toxicity into mammal. These features make the substances of this invention become very useful on many applications.

This invention refer to a series of substances according to formula I: ##STR00001## The substances according to formula I above, known as sulphate chelating agent have the ability to enlarge/loosen simple cell membrane nor common organic membrane and its synthesis process. Furthermore, these invented substances have the potential as the biocides raw material, with very low toxicity into mammal. These features make the substances of this invention become very useful on many applications.

A coating composition including about 5 wt % to about 70 wt % of a latex or a water-dispersible film forming polymer, based on the total weight of the coating composition, a surfactant present in the coating composition at 0.1% to about 1% on the continuous phase of the coating composition; a polymeric associative thickener present in the coating composition at about 0.1% to about 2% on the continuous phase of the coating composition; about 0.1 wt % to about 5 wt % a styrene acrylic resin, based on the total weight of the coating composition; and an aqueous diluent.

Gluconamide sulfates that may be used in consumer products to provide surfactant properties.